Share this post:

To understand better how our forthcoming Antimicrobial Resistance Benchmark was developed and how this tool will be used to track pharmaceutical company action to tackle AMR, Carola Timmel from Semmelweis interviews our Executive Director Jayasree K. Iyer.



Related posts